Loading…

SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE

Inhalation studies were conducted to determine the potential toxicity and or potential neurotoxicity of cyclohexane. Groups of rats and mice were exposed to 0, 500, 2000, or 7000 ppm concentrations of cyclohexane vapor 6 hr day, 5 days week for 14 weeks. Subgroups of rats and mice were further obser...

Full description

Saved in:
Bibliographic Details
Published in:Drug and chemical toxicology (New York, N.Y. 1978) N.Y. 1978), 2000-01, Vol.23 (4), p.513-537
Main Authors: Malley, Linda Angevine, Bamberger, John R., Stadler, Judith C., Elliott, Glenn S., Hansen, John F., Chiu, Taisan, Grabowski, John S., Pavkov, Kenneth L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93
cites cdi_FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93
container_end_page 537
container_issue 4
container_start_page 513
container_title Drug and chemical toxicology (New York, N.Y. 1978)
container_volume 23
creator Malley, Linda Angevine
Bamberger, John R.
Stadler, Judith C.
Elliott, Glenn S.
Hansen, John F.
Chiu, Taisan
Grabowski, John S.
Pavkov, Kenneth L.
description Inhalation studies were conducted to determine the potential toxicity and or potential neurotoxicity of cyclohexane. Groups of rats and mice were exposed to 0, 500, 2000, or 7000 ppm concentrations of cyclohexane vapor 6 hr day, 5 days week for 14 weeks. Subgroups of rats and mice were further observed during a 1-month recovery period. Functional observational battery (FOB) and motor activity (MA) behavioral tests were conducted on rats. These tests were conducted prior to the exposure series and during weeks 4, 8, and 13 on non-exposure days. Clinical pathology evaluations were conducted after approximately 7, 13, and 18 weeks. Approximately 14 and 18 weeks after study initiation, tissues from rats and mice were histologically processed and evaluated by light microscopy. During exposure to 2000 or 7000 ppm, rats and mice had a diminished response or an absent response to delivery of a punctate auditory alerting stimulus. Immediately following removal of rats from the inhalation chambers, 7000 ppm males and females and 2000 ppm females displayed a compound-related increase in the incidence of wet and or stained fur (which occurred in the areas of the mouth, chin, and or perineum). These signs were transient, were not observed during exposure or prior to exposure the following day, and were not associated with any behavioral or morphological changes. During exposure sessions, mice exposed to 7000 ppm exhibited clinical signs of toxicity which included hyperactivity, circling, jumping hopping, excessive grooming, kicking of rear legs, standing on front legs, and occasional flipping behavior. Clinical signs of toxicity observed in 7000 ppm mice immediately after exposure included hyperactivity, hyperreactivity, ruffled fur (females only), gait abnormalities, spasms in both rear legs, and excessive grooming (males only). The clinical signs observed in mice during and immediately after exposure were transient, and were not present prior to the subsequent exposure. A few mice exposed to 2000 ppm appeared hyperactive during exposure in the latter portion of the study. There were no compound-related changes in mean body weights, body weight gains, food consumption, food efficiency, or mortality; and there were no ophthalmological abnormalities in rats or mice. In addition, there were no compound-related effects on 37 different behavioral parameters assessed during the FOB or during motor activity tests in rats. Male and female mice exposed to 7000 ppm had slight i
doi_str_mv 10.1081/DCT-100101969
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_11071393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17751356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93</originalsourceid><addsrcrecordid>eNp1kE1r4zAQhkXpss22e-y1CAp7867GsvxxdFV34yW1S-JAchKSLNMUJ06lhKX_flWSbemhlxkYnpl5eRC6BPITSAq_bnkTACFAIIuzEzQCFrIgJhCdopGvaUBYxM7QN-eePBVmjH5FZwAkAZrREfozm9_w8bSuSo6belHyslni-g7zJZ_U42KRVwUuKzzNmxnOq1t8X_IC3yz9bJxP8qasK1wsHurZfFpcoC-d7J35fuznaH5XNHwcTOrfJc8ngWYAuyBi_ncIplWGplmopNKQtvo1kFIRxCptOxVGOqGaKl8khExDSGLWaSbbjJ6jH4e7Wzs8743bifXKadP3cmOGvROQJAwoiz0YHEBtB-es6cTWrtbSvggg4lWe8PLEmzzPXx0P79XatO_00ZYHro-AdFr2nZUbvXJvXJJmFEJPpQdqtekGu5Z_B9u3Yidf-sH-X6GfJUg-rD4a2e8etbRGPA17u_FaP8n-D3X5kx4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17751356</pqid></control><display><type>article</type><title>SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Malley, Linda Angevine ; Bamberger, John R. ; Stadler, Judith C. ; Elliott, Glenn S. ; Hansen, John F. ; Chiu, Taisan ; Grabowski, John S. ; Pavkov, Kenneth L.</creator><creatorcontrib>Malley, Linda Angevine ; Bamberger, John R. ; Stadler, Judith C. ; Elliott, Glenn S. ; Hansen, John F. ; Chiu, Taisan ; Grabowski, John S. ; Pavkov, Kenneth L.</creatorcontrib><description>Inhalation studies were conducted to determine the potential toxicity and or potential neurotoxicity of cyclohexane. Groups of rats and mice were exposed to 0, 500, 2000, or 7000 ppm concentrations of cyclohexane vapor 6 hr day, 5 days week for 14 weeks. Subgroups of rats and mice were further observed during a 1-month recovery period. Functional observational battery (FOB) and motor activity (MA) behavioral tests were conducted on rats. These tests were conducted prior to the exposure series and during weeks 4, 8, and 13 on non-exposure days. Clinical pathology evaluations were conducted after approximately 7, 13, and 18 weeks. Approximately 14 and 18 weeks after study initiation, tissues from rats and mice were histologically processed and evaluated by light microscopy. During exposure to 2000 or 7000 ppm, rats and mice had a diminished response or an absent response to delivery of a punctate auditory alerting stimulus. Immediately following removal of rats from the inhalation chambers, 7000 ppm males and females and 2000 ppm females displayed a compound-related increase in the incidence of wet and or stained fur (which occurred in the areas of the mouth, chin, and or perineum). These signs were transient, were not observed during exposure or prior to exposure the following day, and were not associated with any behavioral or morphological changes. During exposure sessions, mice exposed to 7000 ppm exhibited clinical signs of toxicity which included hyperactivity, circling, jumping hopping, excessive grooming, kicking of rear legs, standing on front legs, and occasional flipping behavior. Clinical signs of toxicity observed in 7000 ppm mice immediately after exposure included hyperactivity, hyperreactivity, ruffled fur (females only), gait abnormalities, spasms in both rear legs, and excessive grooming (males only). The clinical signs observed in mice during and immediately after exposure were transient, and were not present prior to the subsequent exposure. A few mice exposed to 2000 ppm appeared hyperactive during exposure in the latter portion of the study. There were no compound-related changes in mean body weights, body weight gains, food consumption, food efficiency, or mortality; and there were no ophthalmological abnormalities in rats or mice. In addition, there were no compound-related effects on 37 different behavioral parameters assessed during the FOB or during motor activity tests in rats. Male and female mice exposed to 7000 ppm had slight increases in measures of circulating erythrocyte mass (red blood cells, hemoglobin, hematocrit) and plasma protein concentration (males only). Male rats and male and female mice exposed to 7000 ppm had significantly increased relative liver weights, and 7000 ppm male mice also had significantly increased absolute liver weights at the end of the exposure period. At the end of the 1-month recovery period, absolute and relative liver weights of male and female mice were similar to control. However, relative liver weights of 7000 ppm male rats continued to be significantly higher at the end of the recovery period. Male and female rats exposed to 7000 ppm had a significantly increased incidence of hepatic centrilobular hypertrophy at the end of the exposure period, which was not observed at the conclusion of the 1-month recovery period. No microscopic changes were observed in mice. In rats, the no-observed-effect level (NOEL) for acute, transient effects was 500 ppm based on a diminished absent response to an auditory alerting stimulus at 2000 ppm and above. The NOEL for subchronic toxicity in rats was 7000 ppm based on the lack of adverse effects on body weight, clinical chemistry, tissue morphology, and neurobehavioral parameters. In mice, the NOEL for acute, transient effects was 500 ppm based on behavioral changes during exposure at 2000 ppm and above. The NOEL for subchronic toxicity in mice is 2000 ppm based on hematological changes at 7000 ppm.</description><identifier>ISSN: 0148-0545</identifier><identifier>EISSN: 1525-6014</identifier><identifier>DOI: 10.1081/DCT-100101969</identifier><identifier>PMID: 11071393</identifier><language>eng</language><publisher>New York, NY: Informa UK Ltd</publisher><subject>Animals ; Biological and medical sciences ; Chemical and industrial products toxicology. Toxic occupational diseases ; cyclohexane ; Cyclohexanes - pharmacokinetics ; Cyclohexanes - toxicity ; Erythrocytes - drug effects ; Erythrocytes - metabolism ; Female ; Hematocrit ; Hemoglobins - drug effects ; Humans ; Inhalation Exposure - adverse effects ; Liver - drug effects ; Liver - pathology ; Male ; Medical sciences ; Mice ; Motor Activity - drug effects ; No-Observed-Adverse-Effect Level ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Solvents ; Species Specificity ; Toxicity Tests ; Toxicology ; United States ; United States Environmental Protection Agency</subject><ispartof>Drug and chemical toxicology (New York, N.Y. 1978), 2000-01, Vol.23 (4), p.513-537</ispartof><rights>2000 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2000</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93</citedby><cites>FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=789312$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11071393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malley, Linda Angevine</creatorcontrib><creatorcontrib>Bamberger, John R.</creatorcontrib><creatorcontrib>Stadler, Judith C.</creatorcontrib><creatorcontrib>Elliott, Glenn S.</creatorcontrib><creatorcontrib>Hansen, John F.</creatorcontrib><creatorcontrib>Chiu, Taisan</creatorcontrib><creatorcontrib>Grabowski, John S.</creatorcontrib><creatorcontrib>Pavkov, Kenneth L.</creatorcontrib><title>SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE</title><title>Drug and chemical toxicology (New York, N.Y. 1978)</title><addtitle>Drug Chem Toxicol</addtitle><description>Inhalation studies were conducted to determine the potential toxicity and or potential neurotoxicity of cyclohexane. Groups of rats and mice were exposed to 0, 500, 2000, or 7000 ppm concentrations of cyclohexane vapor 6 hr day, 5 days week for 14 weeks. Subgroups of rats and mice were further observed during a 1-month recovery period. Functional observational battery (FOB) and motor activity (MA) behavioral tests were conducted on rats. These tests were conducted prior to the exposure series and during weeks 4, 8, and 13 on non-exposure days. Clinical pathology evaluations were conducted after approximately 7, 13, and 18 weeks. Approximately 14 and 18 weeks after study initiation, tissues from rats and mice were histologically processed and evaluated by light microscopy. During exposure to 2000 or 7000 ppm, rats and mice had a diminished response or an absent response to delivery of a punctate auditory alerting stimulus. Immediately following removal of rats from the inhalation chambers, 7000 ppm males and females and 2000 ppm females displayed a compound-related increase in the incidence of wet and or stained fur (which occurred in the areas of the mouth, chin, and or perineum). These signs were transient, were not observed during exposure or prior to exposure the following day, and were not associated with any behavioral or morphological changes. During exposure sessions, mice exposed to 7000 ppm exhibited clinical signs of toxicity which included hyperactivity, circling, jumping hopping, excessive grooming, kicking of rear legs, standing on front legs, and occasional flipping behavior. Clinical signs of toxicity observed in 7000 ppm mice immediately after exposure included hyperactivity, hyperreactivity, ruffled fur (females only), gait abnormalities, spasms in both rear legs, and excessive grooming (males only). The clinical signs observed in mice during and immediately after exposure were transient, and were not present prior to the subsequent exposure. A few mice exposed to 2000 ppm appeared hyperactive during exposure in the latter portion of the study. There were no compound-related changes in mean body weights, body weight gains, food consumption, food efficiency, or mortality; and there were no ophthalmological abnormalities in rats or mice. In addition, there were no compound-related effects on 37 different behavioral parameters assessed during the FOB or during motor activity tests in rats. Male and female mice exposed to 7000 ppm had slight increases in measures of circulating erythrocyte mass (red blood cells, hemoglobin, hematocrit) and plasma protein concentration (males only). Male rats and male and female mice exposed to 7000 ppm had significantly increased relative liver weights, and 7000 ppm male mice also had significantly increased absolute liver weights at the end of the exposure period. At the end of the 1-month recovery period, absolute and relative liver weights of male and female mice were similar to control. However, relative liver weights of 7000 ppm male rats continued to be significantly higher at the end of the recovery period. Male and female rats exposed to 7000 ppm had a significantly increased incidence of hepatic centrilobular hypertrophy at the end of the exposure period, which was not observed at the conclusion of the 1-month recovery period. No microscopic changes were observed in mice. In rats, the no-observed-effect level (NOEL) for acute, transient effects was 500 ppm based on a diminished absent response to an auditory alerting stimulus at 2000 ppm and above. The NOEL for subchronic toxicity in rats was 7000 ppm based on the lack of adverse effects on body weight, clinical chemistry, tissue morphology, and neurobehavioral parameters. In mice, the NOEL for acute, transient effects was 500 ppm based on behavioral changes during exposure at 2000 ppm and above. The NOEL for subchronic toxicity in mice is 2000 ppm based on hematological changes at 7000 ppm.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>cyclohexane</subject><subject>Cyclohexanes - pharmacokinetics</subject><subject>Cyclohexanes - toxicity</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - metabolism</subject><subject>Female</subject><subject>Hematocrit</subject><subject>Hemoglobins - drug effects</subject><subject>Humans</subject><subject>Inhalation Exposure - adverse effects</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Motor Activity - drug effects</subject><subject>No-Observed-Adverse-Effect Level</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Solvents</subject><subject>Species Specificity</subject><subject>Toxicity Tests</subject><subject>Toxicology</subject><subject>United States</subject><subject>United States Environmental Protection Agency</subject><issn>0148-0545</issn><issn>1525-6014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp1kE1r4zAQhkXpss22e-y1CAp7867GsvxxdFV34yW1S-JAchKSLNMUJ06lhKX_flWSbemhlxkYnpl5eRC6BPITSAq_bnkTACFAIIuzEzQCFrIgJhCdopGvaUBYxM7QN-eePBVmjH5FZwAkAZrREfozm9_w8bSuSo6belHyslni-g7zJZ_U42KRVwUuKzzNmxnOq1t8X_IC3yz9bJxP8qasK1wsHurZfFpcoC-d7J35fuznaH5XNHwcTOrfJc8ngWYAuyBi_ncIplWGplmopNKQtvo1kFIRxCptOxVGOqGaKl8khExDSGLWaSbbjJ6jH4e7Wzs8743bifXKadP3cmOGvROQJAwoiz0YHEBtB-es6cTWrtbSvggg4lWe8PLEmzzPXx0P79XatO_00ZYHro-AdFr2nZUbvXJvXJJmFEJPpQdqtekGu5Z_B9u3Yidf-sH-X6GfJUg-rD4a2e8etbRGPA17u_FaP8n-D3X5kx4</recordid><startdate>20000101</startdate><enddate>20000101</enddate><creator>Malley, Linda Angevine</creator><creator>Bamberger, John R.</creator><creator>Stadler, Judith C.</creator><creator>Elliott, Glenn S.</creator><creator>Hansen, John F.</creator><creator>Chiu, Taisan</creator><creator>Grabowski, John S.</creator><creator>Pavkov, Kenneth L.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20000101</creationdate><title>SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE</title><author>Malley, Linda Angevine ; Bamberger, John R. ; Stadler, Judith C. ; Elliott, Glenn S. ; Hansen, John F. ; Chiu, Taisan ; Grabowski, John S. ; Pavkov, Kenneth L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>cyclohexane</topic><topic>Cyclohexanes - pharmacokinetics</topic><topic>Cyclohexanes - toxicity</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - metabolism</topic><topic>Female</topic><topic>Hematocrit</topic><topic>Hemoglobins - drug effects</topic><topic>Humans</topic><topic>Inhalation Exposure - adverse effects</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Motor Activity - drug effects</topic><topic>No-Observed-Adverse-Effect Level</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Solvents</topic><topic>Species Specificity</topic><topic>Toxicity Tests</topic><topic>Toxicology</topic><topic>United States</topic><topic>United States Environmental Protection Agency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malley, Linda Angevine</creatorcontrib><creatorcontrib>Bamberger, John R.</creatorcontrib><creatorcontrib>Stadler, Judith C.</creatorcontrib><creatorcontrib>Elliott, Glenn S.</creatorcontrib><creatorcontrib>Hansen, John F.</creatorcontrib><creatorcontrib>Chiu, Taisan</creatorcontrib><creatorcontrib>Grabowski, John S.</creatorcontrib><creatorcontrib>Pavkov, Kenneth L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Drug and chemical toxicology (New York, N.Y. 1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malley, Linda Angevine</au><au>Bamberger, John R.</au><au>Stadler, Judith C.</au><au>Elliott, Glenn S.</au><au>Hansen, John F.</au><au>Chiu, Taisan</au><au>Grabowski, John S.</au><au>Pavkov, Kenneth L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE</atitle><jtitle>Drug and chemical toxicology (New York, N.Y. 1978)</jtitle><addtitle>Drug Chem Toxicol</addtitle><date>2000-01-01</date><risdate>2000</risdate><volume>23</volume><issue>4</issue><spage>513</spage><epage>537</epage><pages>513-537</pages><issn>0148-0545</issn><eissn>1525-6014</eissn><abstract>Inhalation studies were conducted to determine the potential toxicity and or potential neurotoxicity of cyclohexane. Groups of rats and mice were exposed to 0, 500, 2000, or 7000 ppm concentrations of cyclohexane vapor 6 hr day, 5 days week for 14 weeks. Subgroups of rats and mice were further observed during a 1-month recovery period. Functional observational battery (FOB) and motor activity (MA) behavioral tests were conducted on rats. These tests were conducted prior to the exposure series and during weeks 4, 8, and 13 on non-exposure days. Clinical pathology evaluations were conducted after approximately 7, 13, and 18 weeks. Approximately 14 and 18 weeks after study initiation, tissues from rats and mice were histologically processed and evaluated by light microscopy. During exposure to 2000 or 7000 ppm, rats and mice had a diminished response or an absent response to delivery of a punctate auditory alerting stimulus. Immediately following removal of rats from the inhalation chambers, 7000 ppm males and females and 2000 ppm females displayed a compound-related increase in the incidence of wet and or stained fur (which occurred in the areas of the mouth, chin, and or perineum). These signs were transient, were not observed during exposure or prior to exposure the following day, and were not associated with any behavioral or morphological changes. During exposure sessions, mice exposed to 7000 ppm exhibited clinical signs of toxicity which included hyperactivity, circling, jumping hopping, excessive grooming, kicking of rear legs, standing on front legs, and occasional flipping behavior. Clinical signs of toxicity observed in 7000 ppm mice immediately after exposure included hyperactivity, hyperreactivity, ruffled fur (females only), gait abnormalities, spasms in both rear legs, and excessive grooming (males only). The clinical signs observed in mice during and immediately after exposure were transient, and were not present prior to the subsequent exposure. A few mice exposed to 2000 ppm appeared hyperactive during exposure in the latter portion of the study. There were no compound-related changes in mean body weights, body weight gains, food consumption, food efficiency, or mortality; and there were no ophthalmological abnormalities in rats or mice. In addition, there were no compound-related effects on 37 different behavioral parameters assessed during the FOB or during motor activity tests in rats. Male and female mice exposed to 7000 ppm had slight increases in measures of circulating erythrocyte mass (red blood cells, hemoglobin, hematocrit) and plasma protein concentration (males only). Male rats and male and female mice exposed to 7000 ppm had significantly increased relative liver weights, and 7000 ppm male mice also had significantly increased absolute liver weights at the end of the exposure period. At the end of the 1-month recovery period, absolute and relative liver weights of male and female mice were similar to control. However, relative liver weights of 7000 ppm male rats continued to be significantly higher at the end of the recovery period. Male and female rats exposed to 7000 ppm had a significantly increased incidence of hepatic centrilobular hypertrophy at the end of the exposure period, which was not observed at the conclusion of the 1-month recovery period. No microscopic changes were observed in mice. In rats, the no-observed-effect level (NOEL) for acute, transient effects was 500 ppm based on a diminished absent response to an auditory alerting stimulus at 2000 ppm and above. The NOEL for subchronic toxicity in rats was 7000 ppm based on the lack of adverse effects on body weight, clinical chemistry, tissue morphology, and neurobehavioral parameters. In mice, the NOEL for acute, transient effects was 500 ppm based on behavioral changes during exposure at 2000 ppm and above. The NOEL for subchronic toxicity in mice is 2000 ppm based on hematological changes at 7000 ppm.</abstract><cop>New York, NY</cop><pub>Informa UK Ltd</pub><pmid>11071393</pmid><doi>10.1081/DCT-100101969</doi><tpages>25</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0148-0545
ispartof Drug and chemical toxicology (New York, N.Y. 1978), 2000-01, Vol.23 (4), p.513-537
issn 0148-0545
1525-6014
language eng
recordid cdi_pubmed_primary_11071393
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Biological and medical sciences
Chemical and industrial products toxicology. Toxic occupational diseases
cyclohexane
Cyclohexanes - pharmacokinetics
Cyclohexanes - toxicity
Erythrocytes - drug effects
Erythrocytes - metabolism
Female
Hematocrit
Hemoglobins - drug effects
Humans
Inhalation Exposure - adverse effects
Liver - drug effects
Liver - pathology
Male
Medical sciences
Mice
Motor Activity - drug effects
No-Observed-Adverse-Effect Level
Random Allocation
Rats
Rats, Sprague-Dawley
Solvents
Species Specificity
Toxicity Tests
Toxicology
United States
United States Environmental Protection Agency
title SUBCHRONIC TOXICITY OF CYCLOHEXANE IN RATS AND MICE BY INHALATION EXPOSURE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SUBCHRONIC%20TOXICITY%20OF%20CYCLOHEXANE%20IN%20RATS%20AND%20MICE%20BY%20INHALATION%20EXPOSURE&rft.jtitle=Drug%20and%20chemical%20toxicology%20(New%20York,%20N.Y.%201978)&rft.au=Malley,%20Linda%20Angevine&rft.date=2000-01-01&rft.volume=23&rft.issue=4&rft.spage=513&rft.epage=537&rft.pages=513-537&rft.issn=0148-0545&rft.eissn=1525-6014&rft_id=info:doi/10.1081/DCT-100101969&rft_dat=%3Cproquest_pubme%3E17751356%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-4507121edbe3892babc18dc0713bb416b8dfb24c73c3b73ca125c12065fc5ad93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17751356&rft_id=info:pmid/11071393&rfr_iscdi=true